U.S. policy has come a long way from just two years ago when government officials declared that the pricing and affordability of Covid-19 vaccines should be left to the free market. Not ensuring affordability would have implied that ability to pay would determine who gets vaccine access.
Covid-19 Pandemic Produces Shift In U.S. Policy On Providing Free Access To Tests, Vaccines, And Treatments During Public Health Emergencies
